BridgeMD
New treatment option for Aortic Valve Stenosis and Insufficiency
Official title Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial
ClinicalTrials.gov ID: NCT07107568
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether a non-invasive coronary assessment strategy using photon-counting detector computed tomography (PCD-CT) is non-inferior to invasive coronary angiography (ICA) for evaluating coronary artery disease (CAD) prior to transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Severe aortic valve stenosis and indication for intervention according to current European Society of Cardiology (ESC) guidelines
- TAVR candidate
- Written informed consent
You likely can't join if
- Cardiogenic shock at presentation (e.g., emergency indication for TAVR)
- Severe renal impairment with an estimated glomerular filtration rate of \<30 mL/min/1.73 m²
- Life expectancy \<1 year due to other severe non-cardiac disease (e.g., malignancy)
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Innsbruck, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Innsbruck, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.